AI
Moderna and Merck Achieve Milestone With AI-Designed Cancer Therapy
Moderna and Merck have reported positive Phase 3 results for an AI-driven, personalized cancer vaccine, marking a milestone in individualized medicine.
September 14, 2026, 11:06 PM·PYMNTS.com
